MNSO is not a clear buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some supportive fundamentals like an active buyback program and bullish option sentiment, but the current technical picture is mixed-to-bearish, and there is no Intellectia proprietary buy signal. My direct view: wait rather than buy immediately.
Current price is 11.9152, slightly above the pivot at 11.686 and below resistance at 12.118, which means the stock is pressing into overhead supply. MACD histogram is positive and expanding, which is a short-term bullish sign, but RSI_6 at 40.468 is still neutral and not showing strong momentum. The bigger issue is the moving average structure: SMA_200 > SMA_20 > SMA_5, which is bearish and indicates the broader trend is still weak. The pattern-based trend also suggests limited near-term upside, with only modest next-day strength and weaker performance over the next month.

MINISO announced a 2026 share repurchase program of up to HKD 2 billion, funded by surplus cash, which is shareholder-friendly and can support the stock. The company has already repurchased about HKD 1.37 billion under the extended 2024 program, showing consistent capital return activity. Options positioning is call-skewed on open interest, and analyst commentary still includes an Overweight rating from JPMorgan.
The stock is trading below key near-term resistance and its medium-term moving average structure remains bearish. No strong AI Stock Picker or SwingMax signal is present today. Analyst price target was cut sharply by JPMorgan from 26 to 16, indicating reduced upside expectations even though the rating stayed Overweight. Insider and hedge fund activity are both neutral, and there is no recent congress trading data to provide an additional bullish catalyst.
No usable latest-quarter financial snapshot was provided because of the data error, so I cannot assess revenue, earnings, or margin growth for the latest quarter season. Based on the available news and analyst data, the market appears to still value MINISO as a growth-and-capital-return story, but the fundamental quarter-by-quarter performance cannot be confirmed from the provided dataset.
Analyst sentiment is still constructive but less aggressive than before. On 2026-05-29, JPMorgan's Kevin Yin lowered the price target to 16 from 26 while keeping an Overweight rating, which means the pros still see upside but with lower conviction than previously. Overall Wall Street appears mixed: positive on the business and buybacks, but less enthusiastic on near-term upside after the target cut.